Jasper Therapeutics, Inc. · NASDAQ:JSPR
Morgan Stanley's stake in Jasper Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Morgan Stanley's stake in Jasper Therapeutics, Inc. fell to 4.80%, 1,333,420 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 1,333,420
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 4.80% | 1,333,420 |
| Morgan Stanley Capital Services LLC | 4.60% | 1,294,420 |
Source
Related
- Jasper Therapeutics, Inc.
- Morgan Stanley
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 11, 2026
- Schedule 13G/A · Morgan Stanley · Nov 7, 2025
- Schedule 13G · Morgan Stanley · Aug 6, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026